Home/Filings/4/0001609351-17-000050
4//SEC Filing

Spark Therapeutics, Inc. 4

Accession 0001609351-17-000050

CIK 0001609351operating

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:06 PM ET

Size

7.5 KB

Accession

0001609351-17-000050

Insider Transaction Report

Form 4
Period: 2017-05-31
SIGAL ELLIOT
Director
Transactions
  • Award

    Restricted Stock Units

    2017-05-31+1,5001,500 total
    Common Stock (1,500 underlying)
  • Award

    Stock Option (right to buy)

    2017-05-31+4,0004,000 total
    Exercise: $50.93Exp: 2027-05-30Common Stock (4,000 underlying)
Footnotes (3)
  • [F1]100% of the shares vest on the one-year anniversary of the grant date.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
  • [F3]100% of the restricted stock units vest on the one-year anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date.

Issuer

Spark Therapeutics, Inc.

CIK 0001609351

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001609351

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:06 PM ET
Size
7.5 KB